Suppr超能文献

重组人肿瘤坏死因子样配体TL1A的纯化与结晶

Purification and crystallization of recombinant human TNF-like ligand TL1A.

作者信息

Jin Tengchuan, Kim Sunghee, Guo Feng, Howard Andrew, Zhang Yu-Zhu

机构信息

Department of Biology, Illinois Institute of Technology, 3101 South Dearborn Street, LS 182, Chicago, IL 60616, USA.

出版信息

Cytokine. 2007 Nov;40(2):115-22. doi: 10.1016/j.cyto.2007.07.193. Epub 2007 Oct 1.

Abstract

TL1A is a recently discovered TNF-like ligand. Because of the interests in the structural basis of the specificity of the bindings of the TNF ligands to the TNF receptors, we sought to crystallize the mature soluble form of human TL1A. To prepare recombinant human TL1A, the coding sequence for mature human soluble TL1A (aa72-aa251) was cloned into Escherichia coli expression vector pDEST14 and the protein was purified in a succession of immobilized metal affinity, hydrophobic interaction, ion exchange and size exclusion chromatography, indicating that mature TL1A may have a metal ligand. The functional activity of recombinant TL1A was confirmed by its ability to bind to DcR3, a soluble decoy receptor of the TNF receptor family that has been previously reported to bind to TL1A. Single crystals of TL1A were obtained in a screen with a crystal screen kit using the hanging-drop vapor diffusion method. Diffraction quality crystals were grown after optimization. TL1A crystals belong to the tetragonal space group P4(1)2(1)2, with unit cell parameter of a=b=116.734, c=118.927A. The TL1A crystals diffracted to at least 3.2A. Self-rotation functions showed that there are three molecules in the asymmetry unit. Assuming an average partial specific volume of 0.74cm(3)g(-1) for proteins, the water content of the crystal is 62.8%. A preliminary molecular replacement solution was obtained with three TL1A molecules in the asymmetric unit. The three protomers are related by a non-crystallographic 3-fold axis, like those of other TNF ligand family members.

摘要

TL1A是一种最近发现的肿瘤坏死因子样配体。由于对肿瘤坏死因子配体与肿瘤坏死因子受体结合特异性的结构基础感兴趣,我们试图使人类TL1A的成熟可溶性形式结晶。为了制备重组人TL1A,将成熟人可溶性TL1A(aa72 - aa251)的编码序列克隆到大肠杆菌表达载体pDEST14中,并通过一系列固定金属亲和、疏水相互作用、离子交换和尺寸排阻色谱法纯化该蛋白,这表明成熟TL1A可能有一个金属配体。重组TL1A的功能活性通过其与DcR3结合的能力得到证实,DcR3是肿瘤坏死因子受体家族的一种可溶性诱饵受体,此前已报道它能与TL1A结合。使用悬滴气相扩散法,通过晶体筛选试剂盒在筛选中获得了TL1A的单晶。优化后生长出了衍射质量良好的晶体。TL1A晶体属于四方晶系空间群P4(1)2(1)2,晶胞参数a = b = 116.734,c = 118.927Å。TL1A晶体的衍射极限为至少3.2Å。自旋转函数表明不对称单位中有三个分子。假设蛋白质的平均偏比容为0.74cm³g⁻¹,晶体的水含量为62.8%。通过将三个TL1A分子置于不对称单位中获得了初步的分子置换解。这三个原体通过一个非晶体学的三重轴相关联,就像其他肿瘤坏死因子配体家族成员一样。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验